FineMark National Bank & Trust’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-5,680
| Closed | -$118K | – | 354 |
|
|
2018
Q2 | $118K | Buy |
+5,680
| New | +$118K | 0.01% | 391 |
|
|
2018
Q1 | – | Sell |
-7,180
| Closed | -$78K | – | 396 |
|
|
2017
Q4 | $78K | Hold |
7,180
| – | – | 0.01% | 362 |
|
|
2017
Q3 | $86K | Hold |
7,180
| – | – | 0.01% | 365 |
|
|
2017
Q2 | $123K | Hold |
7,180
| – | – | 0.01% | 347 |
|
|
2017
Q1 | $123K | Hold |
7,180
| – | – | 0.01% | 358 |
|
|
2016
Q4 | $123K | Hold |
7,180
| – | – | 0.01% | 426 |
|
|
2016
Q3 | $216K | Hold |
7,180
| – | – | 0.02% | 314 |
|
|
2016
Q2 | $203K | Hold |
7,180
| – | – | 0.02% | 307 |
|
|
2016
Q1 | $192K | Hold |
7,180
| – | – | 0.02% | 307 |
|
|
2015
Q4 | $346K | Hold |
7,180
| – | – | 0.04% | 244 |
|
|
2015
Q3 | $262K | Hold |
7,180
| – | – | 0.04% | 288 |
|
|
2015
Q2 | $271K | Hold |
7,180
| – | – | 0.04% | 294 |
|
|
2015
Q1 | $284K | Hold |
7,180
| – | – | 0.04% | 287 |
|
|
2014
Q4 | $295K | Sell |
7,180
-1,820
| -20% | -$74.8K | 0.04% | 282 |
|
|
2014
Q3 | $398K | Buy |
9,000
+4,000
| +80% | +$177K | 0.06% | 229 |
|
|
2014
Q2 | $217K | Hold |
5,000
| – | – | 0.04% | 320 |
|
|
2014
Q1 | $205K | Hold |
5,000
| – | – | 0.04% | 309 |
|
|
2013
Q4 | $199K | Buy |
5,000
+2,500
| +100% | +$99.5K | 0.04% | 311 |
|
|
2013
Q3 | $103K | Hold |
2,500
| – | – | 0.03% | 411 |
|
|
2013
Q2 | $97K | Buy |
+2,500
| New | +$97K | 0.03% | 399 |
|